Table 3. Comparison of good outcome and poor outcome in patients with BAD and LD.

	BAD			LD
	Good outcome	Poor outcome	P	Good outcome	Poor outcome	P
	N = 103	N = 76		N = 93	N = 36
Age, mean±SD	62.94±11.76	63.79±12.77	0.646	65.38±12.52	66.78±11.66	0.562
Gender, male, n (%)	72(69.9)	49(64.5)	0.443	65(70.0)	21(58.3)	0.212
CRP, median (IQR), mg/L	2.1(0.9–5.06)	3.15(1.7–5.03)	0.006**	2.6(1.2–4.65)	2.8(1.42–7.93)	0.355
Hcy, mean±SD, umol/L	14.64±6.65	13.84±4.79	0.347	16.55±9.57	14.89±4.43	0.183
Hypertension, n (%)	87(84.5)	69(90.8)	0.211	83(89.2)	33(91.7)	0.934
Dyslipidemia, n (%)	90(87.4)	64(84.2)	0.546	73(78.5)	30(83.3)	0.539
Diabetes mellitus, n (%)	36(34.9)	41(53.9)	0.011*	36(38.7)	13(36.1)	0.785
Smoking, n (%)	27(26.2)	29(38.2)	0.088	32(34.4)	9(25.0)	0.303
Ischemic heart disease, n (%)	28(27.2)	31(40.8)	0.056	39(42.0)	17(47.2)	0.587

BAD, branch atheromatous disease; LD, lipohyalinotic degeneration; CRP, C-reactive protein; Hcy, Homocysteine; IQR, interquartile range; Good outcome, Modified Rankin Scale score ≤ 2 point at one month after onset; Poor outcome, Modified Rankin Scale score > 2 point at one month after onset.

^*P<0.05.

^**P<0.01.